MediciNova Announces Development Progress on Intranasal Formulation of SARS-CoV-2 Vaccine for COVID-19

NEXT STORY
Oxford Biomedica Signs Supply Agreement with AstraZeneca to Expand Manufacturing Support of COVID-19 Vaccine Candidate, AZD1222
PREV STORY
Medical Practice Income, Inc., a Subsidiary of USA Equities Corp. (USAQ), Announces the Early Success of QHSLab Launch in South Florida
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Global exosomes market is expected to grow with a CAGR of 17.5% over the forecast period from 2019-2025

author_avatar
NASDAQ Market News

Beroni Group Collaborates with Tianjin University to Develop Novel Solution for Coronavirus (COVID-19)

author_avatar
NASDAQ Market News

Precision BioSciences and Tiziana Life Sciences Announce Exclusive License Agreement to Evaluate Foralumab, a Novel, Fully Human Anti-CD3 Monoclonal Antibody, in Conjunction with Allogeneic CAR T Candidates for Cancer Treatment

author_avatar
NASDAQ Market News